Skip to main content
. 2023 Mar 21;21:210. doi: 10.1186/s12967-023-04051-4

Table 1.

Clinical characteristics of patients in prognostic model

Total Model 1 High risk P_value Model 2 High risk P_value
Low risk Low risk
PDAC patients (n) 66 33 33 33 33
Sex (F [%]) 35 (53.03) 21 (63.64) 14 (21.21) 0.084 21 (63.64) 14 (21.21) 0.084
Age (years) 63.27 ± 10.21 63.73 ± 9.35 62.82 ± 11.14 0.721 65.30 ± 9.88 61.24 ± 10.28 0.107
Grade (n [%])
 1 9 (13.64) 6 (18.18) 3 (9.09) 0.609 6 (18.18) 3 (9.09) 0.233
 2 21 (31.82) 9 (27.27) 12 (36.36) 11 (33.33) 10 (30.30)
 3 36 (54.55) 18 (54.55) 18 (54.55) 16 (48.48) 20 (60.61)
TNM stage (n [%])
 I 28 (42.42) 17 (51.52) 11 (33.33) 0.177 17 (51.52) 11 (33.33) 0.359
 II 16 (24.24) 9 (27.27) 7 (21.21) 8 (24.24) 8 (24.24)
 III 10 (15.15) 4 (12.12) 6 (18.18) 3 (9.09) 7 (21.21)
 IV 12 (18.18) 3 (9.09) 9 (27.27) 5 (15.15) 7 (21.21)
Tumor site (n [%])
 Head 44 (66.67) 20 (60.61) 24 (72.73) 0.296 18 (54.55) 26 (78.79) 0.068
 Body/Tail 22 (33.33) 13 (39.39) 9 (27.27) 15 (45.45) 7 (21.21)
 CA 19–9 (U/ml) 197.15 (68.59–884.13) 173.20 (44.80–821.15) 199.30 (69.08–1000.00) 0.657 212.20 (48.71–821.15) 195.00 (68.58–944.80) 0.944
 Vascular invasion (n [%]) 10 (15.15) 6 (18.18) 4 (12.12) 0.492 5 (15.15) 5 (15.15) 1
 Intravascular cancer embolus (n [%]) 21 (31.82) 9 (27.27) 12 (36.36) 0.428 8 (24.24) 13 (39.39) 0.186
 Perineural invasion (n [%]) 19 (28.79) 9 (27.27) 10 (30.30) 0.786 9 (27.27) 10 (30.30) 0.786
 Peripancreatic infiltarion (n [%]) 48 (72.73) 21 (63.64) 27 (81.82) 0.097 22 (66.67) 26 (78.79) 0.269
 Distant metastasis (n [%]) 11 (16.67) 3 (9.09) 8 (24.24) 0.099 4 (12.12) 7 (21.21) 0.322
 Lymph node metastasis (n [%]) 26 (39.39) 12 (36.36) 14 (42.42) 0.614 11 (33.33) 15 (45.45) 0.314
 Maximum diameter (cm) 3.5 (3.0–4.5) 3.5 (3.0–4.25) 3.5 (2.25–4.5) 0.746 3.5 (3.0–4.5) 3.5 (2.25–4.25) 0.902